Movement Disorders (revue) - Checkpoint (Ncbi)

Index « Auteurs » - entrée « J L Montastruc »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
J L Molinuevo < J L Montastruc < J L Morris  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 14.
Ident.Authors (with country if any)Title
000020 (1999) J L Montastruc [France] ; M. Ziegler ; O. Rascol ; M. MalbezinA randomized, double-blind study of a skin patch of a dopaminergic agonist, piribedil, in Parkinson's disease.
000114 (1999) J L Montastruc [France] ; O. Rascol ; J M SenardTreatment of Parkinson's disease should begin with a dopamine agonist.
000249 (2000) J L MontastrucTreatment of Parkinson's disease should begin with a dopamine agonist.
000511 (2001) J L Montastruc [France] ; K. Desboeuf ; M. Lapeyre-Mestre ; J M Senard ; O. Rascol ; C. Brefel-CourbonLong-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease.
000548 (2001) O. Rascol [France] ; I. Arnulf ; H. Peyro-Saint Paul ; C. Brefel-Courbon ; M. Vidailhet ; C. Thalamas ; A M Bonnet ; S. Descombes ; B. Bejjani ; N. Fabre ; J L Montastruc ; Yves Agid [France]Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease.
000568 (2001) J L Montastruc ; O. RascolModafinil and pramipexole-associated somnolence.
004683 (1987) J L Montastruc [France] ; P. Celsis ; A. Agniel ; J F Demonet ; B. Doyon ; M. Puel ; J P Marc-Vergnes ; A. RascolLevodopa-induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson's disease. Lack of correlation with clinical or neuropsychological improvements.
004739 (1995) J L Montastruc ; N. Fabre ; O. Blin ; J M Senard ; O. Rascol ; A. RascolDoes fluoxetine aggravate Parkinson's disease? A pilot prospective study.
004748 (1995) O. Rascol [France] ; U. Sabatini ; N. Fabre ; J M Senard ; M. Simonetta-Moreau ; J L Montastruc ; M. Clanet ; A. RascolAbnormal vestibuloocular reflex cancellation in multiple system atrophy and progressive supranuclear palsy but not in Parkinson's disease.
004822 (1994) O. Rascol [France] ; N. Fabre ; O. Blin ; J. Poulik ; U. Sabatini ; J M Senard ; M. Ané ; J L Montastruc ; A. RascolNaltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease.
004926 (1994) J L Montastruc ; N. Fabre ; O. Rascol ; J M Senard ; O. BlinN-methyl-D-aspartate (NMDA) antagonist and Parkinson's disease: a pilot study with dextromethorphan.
004C97 (1997) N. Andreu [France] ; C. Damase-Michel ; J M Senard ; O. Rascol ; J L MontastrucA dose-ranging study of selegiline in patients with Parkinson's disease: effect of platelet monoamine oxidase activity.
005006 (1998) O. Rascol [France] ; K. Sieradzan ; H. Peyro-Saint-Paul ; C. Thalamas ; C. Brefel-Courbon ; J M Senard ; P. Ladure ; J L Montastruc ; A. LeesEfaroxan, an alpha-2 antagonist, in the treatment of progressive supranuclear palsy.
005007 (1998) N. Fabre [France] ; C. Brefel ; U. Sabatini ; P. Celsis ; J L Montastruc ; F. Chollet ; O. RascolNormal frontal perfusion in patients with frozen gait.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "J L Montastruc" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i  \
                -Sk "J L Montastruc" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    J L Montastruc
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024